Sfoglia per AUTORE
GIANNARELLI D
Collezione AOU San Luigi di Orbassano

  

Items : 6

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study. in European urology / Eur Urol. 2024 Nov;86(5):411-419. doi: 10.1016/j.eururo.2024.02.014. Epub 2024 Mar 22.

2024
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Buti S; Zucali PA; Fantinel E; Bimbatti D; Verzoni E; Accettura C; Bonomi L; Buttigliero C; Fornarini G; Pipitone S; Atzori F; Masini C; Massari F; Primi F; Strusi A; Giudice GC; Perrino M; Maruzzo M; Milella M; Giannarelli D; Brunelli M; Procopio G; Tortora G;

A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study. in ESMO open / ESMO Open. 2024 Jul;9(7):103624. doi: 10.1016/j.esmoop.2024.103624. Epub 2024 Jun 28.

2024
AOU San Luigi di Orbassano

Avancini A; Giannarelli D; Borsati A; Carnio S; Cantale O; Nepote A; Mangiapane F; Bafunno D; Galetta D; Longo V; Tregnago D; Trestini I; Belluomini L; Sposito M; Insolda J; Schena F; Milella M; Novello S; Pilotto S;

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA). in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Dec 16:S1556-0864(24)02529-2. doi: 10.1016/j.jtho.2024.12.010.

2024
ASL Cuneo 2
ASL Asti
AOU San Luigi di Orbassano

Novello S; Scagliotti G; Righi L; Vallone S; Malapelle U; Volante M; Giannarelli D; Mohorcic K; Meoni G; Scotti V; Linardou H; Bettini AC; Ramizi KM; Secen N; Comanescu A; Felip E; Paz-Ares L; Pignataro D; Araujo A; Barbieri V; Mazilu L; Buffoni L; Taveggia PA; Simionato F; Roca E; Sini C; Tabbò F; Reale ML; Zambelli V; et alii...

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features. in Cancers / Cancers (Basel). 2021 Jun 11;13(12):2935. doi: 10.3390/cancers13122935.

2021
AOU San Luigi di Orbassano

Passaro A; Novello S; Giannarelli D; Bria E; Galetta D; Gelibter A; Reale ML; Carnio S; Vita E; Stefani A; Pizzutilo P; Stati V; Attili I; de Marinis F;

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Dicorato AM; Verusio C; Giordano P; Gernone A; Prati V; Carnio S; Corbo C; Tassinari D; Cavanna L; Meriggi F; Iannopollo M; Sartori D; Longo L; Pezzuolo D; Bonetti A; Mucciarini C; Bracarda S; Fornarini G; Battelli N; Russo A; Lacidogna G; Zucali PA; Sorarù M; Banzi M; Negrini G; Cinieri S; Fratino L; Zustovich F; Mencoboni M; et alii...

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. in Future oncology (London, England) / Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.

2018
AOU San Luigi di Orbassano

Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; Cecere FL; Giannarelli D; Luciani A; Bearz A; Tuzi A; Scotti V; Tonini G; Galetta D; Carta A; Soto Parra H; Rebonato A; Morabito A; Chiari R; Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; et alii...